Ana Perez

Ana Perez is an accomplished finance executive with extensive experience in the biopharmaceutical industry. Currently serving as VP of Finance at AviadoBio since February 2022, Ana specializes in developing transformative medicines for neurodegenerative disorders. Prior roles include Senior Director in International Finance at GW Pharmaceuticals, where efforts focused on cannabis-based therapies, and Senior Director of Financial Planning and Analysis at Orchard Therapeutics, dedicated to innovative gene therapies for rare diseases. Additional experience encompasses positions such as Director of Finance and Business Operations at TESARO UK Limited, Director of FP&A at CRF Health Ltd, Head of Commercial Finance at Norgine Limited, Senior Finance Manager at Gilead Sciences, and Financial Controller EMEA at York International.